Skip to main content
. 2025 Apr 15;17(4):2577–2590. doi: 10.62347/YMXR8481

Table 3.

Evaluation of therapeutic efficacy after treatment in both groups

Tumor response Control group (n = 71) Research group (n = 66) t/χ2 P
CR 5 (7.04) 9 (13.64) 4.955 0.175
PR 18 (25.35) 23 (34.85)
PD 28 (39.44) 15 (22.73)
SD 20 (28.17) 19 (28.79)
ORR 32.39% 48.49% 3.685 0.055
DCR 60.56% 77.27% 4.435 0.035

Note: CR, Complete Response; PR, Partial Response; PD, Progressive Disease; SD, Stable Disease; ORR, Overall Response Rate; DCR, Disease Control Rate.